Metronidazole Pediatric Dosing
For most pediatric infections requiring metronidazole, use 30-40 mg/kg/day divided every 8 hours (maximum 500 mg per dose), but for Clostridium difficile infection specifically, use the lower dose of 7.5 mg/kg/dose three or four times daily (maximum 500 mg per dose) for 10 days. 1, 2
Standard Dosing by Clinical Indication
Clostridium Difficile Infection (CDI)
For non-severe CDI (initial episode or first recurrence):
- 7.5 mg/kg/dose orally three or four times daily for 10 days 1, 3
- Maximum dose: 500 mg per dose 1, 2
- Note: Metronidazole is now considered a weak recommendation with low-quality evidence; vancomycin is preferred when available 1
For severe/fulminant CDI:
- Oral vancomycin is strongly recommended over metronidazole 1, 3
- If metronidazole must be used: 10 mg/kg/dose IV three times daily (maximum 500 mg per dose) 1, 3
- Consider adding IV metronidazole to oral vancomycin in critically ill patients 1
For second or subsequent recurrences:
Intra-Abdominal and Anaerobic Infections
Standard dosing:
- 30-40 mg/kg/day divided every 8 hours 2, 4
- Maximum: 500 mg per dose 2
- Duration: 7-10 days for most infections 2, 4
For mixed necrotizing infections:
- 7.5 mg/kg/dose IV every 6 hours 2
- Typically combined with cefotaxime (50 mg/kg/dose every 6 hours) or other broad-spectrum agents 2
Amebiasis
FDA-approved dosing:
- 35-50 mg/kg/day divided into three doses orally for 10 days 4
Perianal Crohn's Disease
- 10-20 mg/kg/day in divided doses 2
Critical Dosing Distinctions
Recognize that CDI requires LOWER dosing (7.5 mg/kg/dose) compared to other anaerobic infections (10-13 mg/kg/dose or 30-40 mg/kg/day total). 2 This is a common prescribing error that should be avoided.
Administration Considerations
Route of administration:
- Oral bioavailability is generally good, but IV administration may be preferred for severe infections 4
- The usual adult oral dose is 7.5 mg/kg every 6 hours (approximately 500 mg for a 70 kg adult), with a maximum of 4 g per 24-hour period 4
Duration:
- Standard duration is 10 days for most infections 1, 2, 3
- Bone/joint, lower respiratory tract, and endocardium infections may require longer treatment 4
- Avoid extending metronidazole beyond 14 days without compelling justification due to neurotoxicity risk 5
Special Populations and Adjustments
Malnourished children:
- Require significant dose reduction (approximately 60% reduction to 12 mg/kg/day) due to altered biotransformation 6
- Standard dosing may lead to drug accumulation and toxicity 6
Hepatic impairment:
- Doses below usual recommendations should be administered cautiously 4
- Close monitoring of plasma metronidazole levels and toxicity is recommended 4
Renal impairment:
- No specific dose reduction required in anuric patients 4
- Accumulated metabolites are rapidly removed by dialysis 4
Elderly patients:
- Pharmacokinetics may be altered; monitoring of serum levels may be necessary 4
Safety Considerations and Monitoring
Neurotoxicity warning:
- Avoid repeated or prolonged courses due to risk of cumulative and potentially irreversible neurotoxicity 5
- This is particularly important when considering extended therapy 5
Treatment failure in CDI:
- If no response within 5-7 days, switch to oral vancomycin 5
- Current guidelines prefer vancomycin or fidaxomicin over metronidazole when available 5
Common adverse effects:
- Nausea, metallic taste, gastrointestinal discomfort 5
- Mild to moderate adverse events reported in 21% of patients in one study, including nausea (10.8%), diarrhea (8.9%), vomiting (7.1%) 7
Monitoring parameters:
- Complete the full course even if symptoms improve 5
- For repeat courses, perform total and differential leukocyte counts before and after retreatment 4
- Allow 4-6 weeks between repeat courses and reconfirm infection 4
Common Pitfalls to Avoid
- Using the same dose for CDI as for other anaerobic infections - CDI requires lower dosing (7.5 mg/kg/dose vs 10-13 mg/kg/dose) 2
- Prescribing metronidazole as first-line for severe CDI - vancomycin is strongly preferred 1, 3
- Extending therapy beyond 14 days without justification - increases neurotoxicity risk 5
- Failing to adjust doses in malnourished children - can lead to toxicity 6